Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV - US60784B1017 - REIT

15.17 USD
-0.08 (-0.52%)
Last: 8/29/2025, 4:15:01 PM
15.17 USD
0 (0%)
After Hours: 8/29/2025, 4:15:01 PM
Fundamental Rating

4

Overall MDV gets a fundamental rating of 4 out of 10. We evaluated MDV against 129 industry peers in the Diversified REITs industry. MDV has an average financial health and profitability rating. MDV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MDV had negative earnings in the past year.
In the past year MDV had a positive cash flow from operations.
MDV had negative earnings in 4 of the past 5 years.
MDV had a positive operating cash flow in each of the past 5 years.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

MDV has a worse Return On Assets (-0.84%) than 65.89% of its industry peers.
The Return On Equity of MDV (-2.54%) is worse than 65.12% of its industry peers.
MDV has a Return On Invested Capital of 3.18%. This is in the better half of the industry: MDV outperforms 62.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDV is in line with the industry average of 3.06%.
The 3 year average ROIC (2.12%) for MDV is below the current ROIC(3.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.84%
ROE -2.54%
ROIC 3.18%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With an excellent Operating Margin value of 42.28%, MDV belongs to the best of the industry, outperforming 87.60% of the companies in the same industry.
MDV's Operating Margin has improved in the last couple of years.
MDV's Gross Margin of 92.32% is amongst the best of the industry. MDV outperforms 95.35% of its industry peers.
In the last couple of years the Gross Margin of MDV has grown nicely.
Industry RankSector Rank
OM 42.28%
PM (TTM) N/A
GM 92.32%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDV is destroying value.
The number of shares outstanding for MDV has been increased compared to 1 year ago.
The number of shares outstanding for MDV has been increased compared to 5 years ago.
Compared to 1 year ago, MDV has a worse debt to assets ratio.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.11, we must say that MDV is in the distress zone and has some risk of bankruptcy.
MDV has a worse Altman-Z score (0.11) than 72.09% of its industry peers.
MDV has a debt to FCF ratio of 27.29. This is a negative value and a sign of low solvency as MDV would need 27.29 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 27.29, MDV is doing good in the industry, outperforming 70.54% of the companies in the same industry.
MDV has a Debt/Equity ratio of 1.69. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.69, MDV is doing worse than 65.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 27.29
Altman-Z 0.11
ROIC/WACC0.47
WACC6.74%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

MDV has a Current Ratio of 5.44. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
MDV has a Current ratio of 5.44. This is amongst the best in the industry. MDV outperforms 98.45% of its industry peers.
A Quick Ratio of 5.44 indicates that MDV has no problem at all paying its short term obligations.
MDV has a better Quick ratio (5.44) than 98.45% of its industry peers.
Industry RankSector Rank
Current Ratio 5.44
Quick Ratio 5.44
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.08% over the past year.
MDV shows a decrease in Revenue. In the last year, the revenue decreased by -2.40%.
Measured over the past years, MDV shows a quite strong growth in Revenue. The Revenue has been growing by 13.76% on average per year.
EPS 1Y (TTM)98.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%233.33%
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%3.71%

3.2 Future

The Earnings Per Share is expected to grow by 2.94% on average over the next years.
Based on estimates for the next years, MDV will show a small growth in Revenue. The Revenue will grow by 1.92% on average per year.
EPS Next Y-59.6%
EPS Next 2Y-20.87%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue Next Year2.2%
Revenue Next 2Y3.02%
Revenue Next 3Y1.53%
Revenue Next 5Y1.92%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

MDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MDV is valuated quite expensively with a Price/Forward Earnings ratio of 96.90.
MDV's Price/Forward Earnings is on the same level as the industry average.
MDV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.78.
Industry RankSector Rank
PE N/A
Fwd PE 96.9
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

74.42% of the companies in the same industry are more expensive than MDV, based on the Enterprise Value to EBITDA ratio.
81.40% of the companies in the same industry are more expensive than MDV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.04
EV/EBITDA 11.96
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.87%
EPS Next 3Y2.94%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.69%, MDV is a good candidate for dividend investing.
MDV's Dividend Yield is a higher than the industry average which is at 6.31.
MDV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 7.69%

5.2 History

MDV has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MDV are negative and hence is the payout ratio. MDV will probably not be able to sustain this dividend level.
DP-355.77%
EPS Next 2Y-20.87%
EPS Next 3Y2.94%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

MODIV INDUSTRIAL INC

NYSE:MDV (8/29/2025, 4:15:01 PM)

After market: 15.17 0 (0%)

15.17

-0.08 (-0.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)N/A N/A
Inst Owners18.15%
Inst Owner Change39.92%
Ins Owners2.99%
Ins Owner Change1.83%
Market Cap154.13M
Analysts84.44
Price Target17.85 (17.67%)
Short Float %4.01%
Short Ratio5.22
Dividend
Industry RankSector Rank
Dividend Yield 7.69%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-355.77%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-30 2025-09-30 (0.0975)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)159.31%
Min EPS beat(2)88.58%
Max EPS beat(2)230.03%
EPS beat(4)3
Avg EPS beat(4)-44.11%
Min EPS beat(4)-694.06%
Max EPS beat(4)230.03%
EPS beat(8)5
Avg EPS beat(8)-151.36%
EPS beat(12)8
Avg EPS beat(12)115.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.27%
Min Revenue beat(4)-1.28%
Max Revenue beat(4)1.93%
Revenue beat(8)3
Avg Revenue beat(8)-0.61%
Revenue beat(12)5
Avg Revenue beat(12)3.25%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.13%
PT rev (3m)-2.78%
EPS NQ rev (1m)87.55%
EPS NQ rev (3m)183.33%
EPS NY rev (1m)30.43%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)-0.86%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 96.9
P/S 3.28
P/FCF 15.04
P/OCF 8.79
P/B 0.93
P/tB 0.94
EV/EBITDA 11.96
EPS(TTM)-0.02
EYN/A
EPS(NY)0.16
Fwd EY1.03%
FCF(TTM)1.01
FCFY6.65%
OCF(TTM)1.73
OCFY11.37%
SpS4.63
BVpS16.3
TBVpS16.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.84%
ROE -2.54%
ROCE 4.03%
ROIC 3.18%
ROICexc 3.22%
ROICexgc 3.24%
OM 42.28%
PM (TTM) N/A
GM 92.32%
FCFM 21.8%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexcg growth 3Y59.93%
ROICexcg growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 27.29
Debt/EBITDA 7.8
Cap/Depr 45.58%
Cap/Sales 15.49%
Interest Coverage 1.53
Cash Conversion 48.9%
Profit Quality N/A
Current Ratio 5.44
Quick Ratio 5.44
Altman-Z 0.11
F-Score5
WACC6.74%
ROIC/WACC0.47
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%233.33%
EPS Next Y-59.6%
EPS Next 2Y-20.87%
EPS Next 3Y2.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%3.71%
Revenue Next Year2.2%
Revenue Next 2Y3.02%
Revenue Next 3Y1.53%
Revenue Next 5Y1.92%
EBIT growth 1Y96.37%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year79.94%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y109.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.04%
OCF growth 3Y23.3%
OCF growth 5Y30.88%